[2021] Alprazolam Tablets Industry Overview, Top Trends in 2021, Market Review, Size, Share and Growth Insights to 2027

SEATTLE, April 14, 2021, (PHARMIWEB) — Global Alprazolam Tablets Market

Overview

A person’s behavior, mood, and thinking is largely influenced by mental illness or mental health disorders such as panic attacks, depression, anxiety, etc. Such patients who are suffering from panic attacks and anxiety are prescribed a tablet called as Alprazolam. This tablet comes under the category of benzodiazepines drugs which are responsible for producing a calm effect on the nerves and brain through accelerated production of gamma-Aminobutyric acid (GABA) neurotransmitter.

Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/4311

COVID-19 Impact

The COVID-19 outbreak has created some serious psychological problems to the people globally. Increasing cases of anxiety patients has led to acceleration in the production of anti-anxiety tablets and drugs. This has consequently surged the demand for depression-based medications to sustain the treatment of rising patients. In October 2020, the World Health Organization (WHO) reported that over 10% of the global population is suffering from mental disturbances due to COVID-19 lockdowns. The organization also urged the global leaders to increase their investments in psychology-based research and development.

Drivers

Rising cases of people suffering from anxiety globally is expected to drive growth of the global alprazolam tablets market over the forecast period. In June 2020, as per the report from Centers for Disease Control and Prevention (CDC), over 4.3 million aging between 3 and 17 years are diagnosed with anxiety.

Increasing volume of psychological campaigns organized by the regulatory authorities is expected to propel the growth of global alprazolam tablets market over the forecast period. In August 2020, the U.S. Drug Enforcement Administration (DEA), had raised a campaign to combat the trade of production kits such as die punches, chemicals and tablet presses that are utilized in illegal drug synthesis.

Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4311

Restraint

Potential transmission and contamination risk of contagious diseases can halt the production of pharmaceutical companies. This possible risk is expected to hamper the growth of global alprazolam tablet market during the forecast period.

Market Segmentation

According to the form, the global alprazolam tablets market is segmented into:

• Immediate Release Tablets
• Extended-Release Capsules
• Orally Disintegrating Tablets

According to the application, the global alprazolam tablets market is segmented into:

• Anxiety Disorder
• Panic Attacks
• Others

According to the region, the global alprazolam tablets market is segmented into:

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa

Regional Insights

North America is expected to witness a significant growth in the global alprazolam tablets market over the forecast period. Rising anxiety-prone population of the U.S. is driving the growth of alprazolam tablet market in this region. As per the report from Anxiety and Depression Association of America (ADAA), there are 40 million U.S. adults who are suffering anxiety disorders in 2020 after the COVID-19 pandemic emergence.

Europe is also expected to experience a robust growth in the global alprazolam tablets market during the forecast period. New policies for health treatment of mental problems are driving the growth of alprazolam tablet market in this region.

To get detailed table of content (ToC), please click – https://www.coherentmarketinsights.com/ongoing-insight/toc/4311

Competitive Landscape

The major players contributing in the global alprazolam tablet market are Aurobindo Pharma Ltd., Mylan N.V., Par Pharmaceuticals, Pfizer Inc., Taj Pharmaceuticals Ltd., Terrace Pharmaceuticals, Avalanche Pharmaceuticals Pvt. Ltd., Cooper Pharma Ltd., Sun Pharmaceuticals Industries Ltd., Cadila Pharmaceuticals Ltd., Lupin Limited, and Novartis International AG.

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837